Rinvoq is back as the lead Rx and over-the-counter (OTC) pharma brand, according to data released by iSpot on Friday morning.
AbbVie’s ulcerative colitis, arthritis and eczema treatment generated an impressions share of voice (SOV) of 3.66% during March, topping the list of the lead 10 Rx and OTC brands.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,